Biotechnology/Pharmaceuticals  
 
Home
About Us
Biotech/Pharma
Careers
Clinical Trials
FDA
Medicare/Managed Care
New Drug Applications
Regulation
Stock Selection
Contact Us
  Hot News
 

 

 

 


  Info Box

 

 

 

 

 


 
  • Late Corey Haim linked to prescription drug ring (AFP)

    AFP - Prosecutors in California have said they are looking into a possible link between the death of Canadian actor Corey Haim and an illegal trade in prescription drugs.




  • Endo names ex-Nora Therapeutics CEO as COO (AP)
    AP - Endo Pharmaceuticals Holdings Inc. said Friday it hired former Nora Therapeutics CEO Julie McHugh as its new chief operating officer.

  • Medco Health got compensation worth $13.3M in 2009 (AP)
    AP - Pharmacy benefits manager Medco Health Solutions Inc. said even though its CEO took a 7 percent pay cut in 2009, he still received $13.3 million in total compensation, according to Associated Press calculation of figures filed with regulators.

  • Optimer Pharma reports narrower 4th-quarter loss (AP)
    AP - Optimer Pharmaceuticals Inc. narrowed its loss in the fourth quarter as expenses declined, the company said.

  • Ligand, Glaxo drug gets European approval (AP)
    AP - Ligand Pharmaceuticals Inc. said Friday that partner GlaxoSmithKline gained European regulatory approval to sell the blood disorder drug Revolade.

  • Aveo Pharmaceutical shares drop in trading debut (AP)
    AP - Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million.

  • NY cashier, 91, punched trying to fend off thief (AP)
    AP - A 91-year-old New York pharmacy cashier refused medical attention and went back to work after a thief punched her.

  • AVEO Pharmaceuticals IPO prices below expectations (AP)
    AP - AVEO Pharmaceuticals Inc.'s initial public offering priced below expectations, resulting in $81 million in proceeds, the biotechnology company said Friday.

  • Pfizer says Sutent fails in breast cancer studies (AP)
    AP - Pfizer Inc. said Thursday the cancer drug Sutent did not meet key goals in two late-stage studies focusing on advanced breast cancer.

  • Pfizer ends study on potential lung cancer drug (AP)
    AP - Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness.

  • Watson says FDA approves 6-month dose Trelstar (AP)
    AP - Watson Pharmaceuticals Inc. said the Food and Drug Administration approved a six-month dose of the prostate cancer drug Trelstar, which already was available in one- and three-month doses.

  • Caraco gets FDA approval for generic Eloxatin (AP)
    AP - Caraco Pharmaceutical Laboratories Ltd. said Thursday it launched a generic version of Sanofi-Aventis' cancer treatment Eloxatin.

  • Astra boosts generic exposure with Torrent deal (AP)
    AP - AstraZeneca PLC announced a supply partnership with India's Torrent Pharmaceuticals on Thursday, its first such link with a generic drugmaker as it seeks to boost its presence in emerging markets and counter patent losses on blockbuster medicines.

  • Affymax receives $5M payment for drug development (AP)
    AP - Biotechnology company Affymax Inc. has received a $5 million milestone payment from Takeda Pharmaceutical Co. for the development of a potential anemia treatment.

  • CVS Caremark declares quarterly dividend (AP)
    AP - Store and mail-order pharmacy operator CVS Caremark Corp. said Wednesday it would pay a quarterly dividend of 8.75 cents per share on May 4 to shareholders of record as of April 23.

  • Pharmaceutical group spent $6.3M lobbying in Q4 (AP)
    AP - The pharmaceutical industry's main trade group spent $6.3 million in the fourth quarter lobbying Congress, the White House and multiple government agencies on health care provisions and related issues, according to a quarterly disclosure report.

  • Walgreen reportedly in drug plan talks with Delta (AP)
    AP - Media reports on Wednesday indicated drugstore chain Walgreen Co. is in talks about a plan to offer prescription drugs directly to employees of Delta Air Lines Inc.

  • Protalix chairman resigns for health reasons (AP)
    AP - Protalix Biotherapeutics Inc., a pharmaceutical company, said Tuesday its chairman of the board is resigning to recover from an illness.

  • Generic drugmaker Teva names Frost as chairman (AP)
    AP - Generic drugmaker Teva Pharmaceutical Industries Ltd. said Tuesday it has appointed vice chairman Dr. Phillip Frost to serve as chairman of its board.

  • Mass. father casts blame in daughter's drug death (AP)
    AP - The Massachusetts man accused of killing his 4-year-old daughter by overmedicating her with prescription drugs is blaming his wife and a psychiatrist for the girl's death in 2006.


  •  

     

     

     

     

     
    Copyright © 2006. BioHQ.com. All rights reserved.